Today, the screeners at HealthTechMovers.com picked up 3 HealthTech Stocks up over 31% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
MarketDailyPress.com is also looking into these tickers BMRN, PEPG, BLCO, COO, SAGE.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Artemis Therapeutics, ATMS
Summary: Artemis Therapeutics Inc. provides healthcare services. The company offers The Artemis Allergy Treatment Program for people suffering from seasonal, environmental or pet allergies. Artemis Therapeutics Inc., formerly known as New York Global Innovations Inc., is based in United States of America.
Recent ATMS Stock Price (approx 10:00am EST.): $3.20
Previous Close for ATMS Stock: $2.7
Percentage Price Change Past 10 Days for ATMS stock: +44%
Click here to get the full story on ATMS stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company's product candidate includes AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. Akouos, Inc. is based in Boston, Massachusetts.
Recent AKUS Stock Price (approx 10:00am EST.): $6.65
Previous Close for AKUS Stock: $6.3
Percentage Price Change Past 10 Days for AKUS stock: +34%
TipRanks.com reports that AKOUOS stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for AKUS stock with an average price target is $24.00.
Click here to get the full story on AKUS stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Evaxion Biotech A/S is a clinical-stage biotechnology company. It involved in the development of AI-driven immunotherapies for patients with cancer and infectious diseases. Evaxion Biotech A/S is based in COPENHAGEN, Denmark.
Recent EVAX Stock Price (approx 10:00am EST.): $2.74
Previous Close for EVAX Stock: $2.77
Percentage Price Change Past 10 Days for EVAX stock: +31%
TipRanks.com reports that Evaxion Biotech stock currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for EVAX stock with an average price target is $16.00.
Click here to get the full story on EVAX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
MarketDailyPress.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to MarketDailyPress.com.